Rivastigmine Transdermal System 51991-0898
Generic: Rivastigmine
Product NDC
51991-0898- Manufacturer
- Breckenridge Pharmaceutical, Inc.
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- Marketing Start
- December 19, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA209063
Need to source Rivastigmine Transdermal System? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rivastigmine | 9.5 mg/24h |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Packaging Options(1)
30 POUCH in 1 CARTON (51991-898-30) / 1 PATCH in 1 POUCH (51991-898-99) / 24 h in 1 PATCH